Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BENRALIZUMAB for Chronic obstructive pulmonary disease: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 131 adverse event reports in the FDA FAERS database where BENRALIZUMAB was used for Chronic obstructive pulmonary disease.

Most Reported Side Effects for BENRALIZUMAB

Side Effect Reports % Deaths Hosp.
Asthma 2,457 15.6% 39 932
Dyspnoea 1,604 10.2% 16 470
Death 1,336 8.5% 1,333 40
Drug ineffective 1,266 8.0% 18 431
Cough 793 5.0% 2 168
Headache 788 5.0% 3 123
Product dose omission issue 713 4.5% 12 169
Pneumonia 710 4.5% 38 403
Wheezing 619 3.9% 0 154
Malaise 514 3.3% 7 143
Fatigue 495 3.2% 3 96
Inappropriate schedule of product administration 456 2.9% 9 141
Pyrexia 455 2.9% 4 144
Arthralgia 437 2.8% 0 51
Rash 435 2.8% 2 52

Other Indications for BENRALIZUMAB

Asthma (9,988) Product used for unknown indication (311) Eosinophil count increased (60) Eosinophilic granulomatosis with polyangiitis (56) Eosinophilia (27) Dyspnoea (24) Hypereosinophilic syndrome (23) Illness (23) Nasal polyps (22) Severe asthma with fungal sensitisation (22)

Other Drugs Used for Chronic obstructive pulmonary disease

TIOTROPIUM (20,175) FLUTICASONE\SALMETEROL (8,896) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (8,730) ALBUTEROL (8,572) BUDESONIDE\FORMOTEROL (6,539) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (4,580) UMECLIDINIUM\VILANTEROL TRIFENATATE (4,512) DUPILUMAB (3,526) ALBUTEROL\IPRATROPIUM (3,289) ACLIDINIUM (2,321)

Related Pages

BENRALIZUMAB Full Profile All Chronic obstructive pulmonary disease Drugs BENRALIZUMAB Demographics BENRALIZUMAB Timeline